[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB2154874B - Bromoscriptine compositions - Google Patents

Bromoscriptine compositions

Info

Publication number
GB2154874B
GB2154874B GB08504788A GB8504788A GB2154874B GB 2154874 B GB2154874 B GB 2154874B GB 08504788 A GB08504788 A GB 08504788A GB 8504788 A GB8504788 A GB 8504788A GB 2154874 B GB2154874 B GB 2154874B
Authority
GB
United Kingdom
Prior art keywords
bromoscriptine
compositions
bromoscriptine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08504788A
Other versions
GB2154874A (en
GB8504788D0 (en
Inventor
Othmar Zugar
Norman Mazer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848405227A external-priority patent/GB8405227D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB08504788A priority Critical patent/GB2154874B/en
Publication of GB8504788D0 publication Critical patent/GB8504788D0/en
Publication of GB2154874A publication Critical patent/GB2154874A/en
Priority to MYPI87001999A priority patent/MY101029A/en
Application granted granted Critical
Publication of GB2154874B publication Critical patent/GB2154874B/en
Priority to CY1564A priority patent/CY1564A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08504788A 1984-02-29 1985-02-25 Bromoscriptine compositions Expired GB2154874B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB08504788A GB2154874B (en) 1984-02-29 1985-02-25 Bromoscriptine compositions
MYPI87001999A MY101029A (en) 1984-02-29 1987-09-28 Bromocriptine compositions
CY1564A CY1564A (en) 1984-02-29 1991-05-17 Bromocriptine compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions
GB08504788A GB2154874B (en) 1984-02-29 1985-02-25 Bromoscriptine compositions

Publications (3)

Publication Number Publication Date
GB8504788D0 GB8504788D0 (en) 1985-03-27
GB2154874A GB2154874A (en) 1985-09-18
GB2154874B true GB2154874B (en) 1987-11-04

Family

ID=26287383

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08504788A Expired GB2154874B (en) 1984-02-29 1985-02-25 Bromoscriptine compositions

Country Status (3)

Country Link
CY (1) CY1564A (en)
GB (1) GB2154874B (en)
MY (1) MY101029A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
CN104013971A (en) * 2014-06-23 2014-09-03 深圳翰宇药业股份有限公司 Bromocriptine composition sustained-release preparation and preparation method thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
NL194822C (en) * 1985-10-01 2003-04-03 Novartis Ag Preparation for oral administration with controlled release and method for its preparation.
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
DE3722383A1 (en) * 1986-07-14 1988-01-28 Sandoz Ag NEW USE OF BROMOCRIPTIN
SE8703881D0 (en) * 1987-10-08 1987-10-08 Haessle Ab NEW PHARMACEUTICAL PREPARATION
IT1235053B (en) * 1989-04-07 1992-06-17 Poli Ind Chimica Spa METHODS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS BASED ON BROMOCRIPTINE EQUIPPED WITH HIGH STABILITY AND DERIVING PRODUCTS.
FR2656525A1 (en) * 1989-12-29 1991-07-05 Delalande Sa Controlled-release pharmaceutical dosage forms and process for manufacturing them
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
CN104013971A (en) * 2014-06-23 2014-09-03 深圳翰宇药业股份有限公司 Bromocriptine composition sustained-release preparation and preparation method thereof

Also Published As

Publication number Publication date
CY1564A (en) 1991-05-17
GB2154874A (en) 1985-09-18
GB8504788D0 (en) 1985-03-27
MY101029A (en) 1991-06-29

Similar Documents

Publication Publication Date Title
SG18692G (en) Liposome-gel compositions
GB8518876D0 (en) Composition
GB8526284D0 (en) Composition
GB8527242D0 (en) Dental-caries-preventative composition
GB8500581D0 (en) Orgaopolysiloxane composition
HK7991A (en) Compositions
GB8412423D0 (en) Polymeric compositions
EP0172025A3 (en) Polymeric compositions
PT80275A (en) Compositions
GB8507516D0 (en) Compositions
GB8521762D0 (en) Detergent-softener compositions
GB8517349D0 (en) Composition
GB8416923D0 (en) Composition
GB2154874B (en) Bromoscriptine compositions
GB8521761D0 (en) Detergent-softener compositions
GB8418082D0 (en) Compositions
GB8524867D0 (en) Ceramics-forming composition
GB8502426D0 (en) Composition
GB8508284D0 (en) Compositions
DE3571121D1 (en) Novel compositions
SG69390G (en) Bromocritine compositions
GB8521760D0 (en) Detergent-softener compositions
GB2158714B (en) Composition
PT79910A (en) Compositions
MW1385A1 (en) Compositions

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 20050224